Abstract
Since the need of sedation during the first experiences of invasive ventilation, the concept of sedation and pain control have been developed and, conceptually, separated. Nowadays, intensive care might need a different level of sedation (intensivists must make the patient in condition to tolerate the “trauma” of intensive care) and pain control (in case of traumatic injury, nursing, invasive maneuvers). Basically, intensivists should decide the level of sedation based on the level of invasive care, the prevision of ICU length of stay, the pain level, and the possibility of human contact maximization. Receptors involved in pharmacological control of consciousness are γ-aminobutyric acid (GABA) receptors, opioid receptors, glutamic acid receptors, and α2 adrenergic receptors. Sedation and pain control are therapies; thus, they must be decided with the same importance as well as antimicrobial or vasoactive support. The modern concept should be based on neurological monitoring, to improve relatives’ contact with the patients. Actually, international opinion remarks the reduction of sedative administration, so increasing the possibility of human contact. In this context, the eCASH concept (early Comfort using Analgesia, minimal Sedatives, and maximal Humane care) recently proposed could became a new point of view in sedation management.
References
Reisner-Sénélar L. The birth of intensive care medicine: Björn Ibsen’s records. Intensive Care Med. 2011;37(7):1084–6.
Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2(5920):656–9.
Olsen RW, Sieghart W. International Union of Pharmacology. LXX. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev. 2008;60:243–60.
Wu Y, Ali S, Ahmadian G, Liu CC, Wang YT, Gibson KM, Calver AR, Francis J, Pangalos MN, Carter Snead O III. Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence. Neuropharmacology. 2004;47(8):1146–56.
Corbett AD, Henderson G, McKnight AT, Paterson SJ. 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol. 2006;147(Suppl 1):S153–62.
Bodnar RJ. Endogenous opiates and behavior: 2014. Peptides. 2014;2016(75):18–70.
Milligan G. G-protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol. 2004;66:1–7.
Patapoutian A, Tate S, Woolf CJ. Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov. 2009;8:55–68.
Watkins JC, Jane DE. The glutamate story. Br J Pharmacol. 2006;147(Suppl. 1):S100–8.
Bleakman D, Lodge D. Neuropharmacology of AMPA and kainate receptors. Neuropharmacology. 1998;37:187–204.
Insel PA. Adrenergic receptors: evolving concepts and clinical implications. N Engl J Med. 1996;334:580–5.
Hall JB. Creating the animated intensive care unit. Crit Care Med. 2011;38(10 Suppl):S668–75.
Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, Coursin DB, Herr DL, Tung A, Robinson BR, Fontaine DK, Ramsay MA, Riker RR, Sessler CN, Pun B, Skrobik Y, Jaeschke R, American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.
Page VJ, McAuley DF. Sedation/drugs used in intensive care sedation. Curr Opin Anaesthesiol. 2015;28:139–44.
DAS-Taskforce 2015, Baron R, Binder A, Biniek R, Braune S, Buerkle H, Dall P, Demirakca S, Eckardt R, Eggers V, Eichler I, Fietze I, Freys S, Fründ A, Garten L, Gohrbandt B, Harth I, Hartl W, Heppner HJ, Horter J, Huth R, Janssens U, Jungk C, Kaeuper KM, Kessler P, Kleinschmidt S, Kochanek M, Kumpf M, Meiser A, Mueller A, Orth M, Putensen C, Roth B, Schaefer M, Schaefers R, Schellongowski P, Schindler M, Schmitt R, Scholz J, Schroeder S, Schwarzmann G, Spies C, Stingele R, Tonner P, Trieschmann U, Tryba M, Wappler F, Waydhas C, Weiss B, Weisshaar G. Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Ger Med Sci. 2015;13:Doc19.
Parker AM, Sricharoenchai T, Raparla S, Schneck KW, Bienvenu OJ, Needham DM. Post-traumatic stress disorder in critical illness survivors: a metaanalysis. Crit Care Med. 2015;43(5):1121–9.
Burry L, Rose L, McCullagh IJ, Fergusson DA, Ferguson ND, Mehta S. Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation. Cochrane Database Syst Rev. 2014;(7):CD009176.
Vincent JL, Shehabi Y, Walsh TS, Pandharipande PP, Ball JA, Spronk P, Longrois D, Strøm T, Conti G, Funk GC, Badenes R, Mantz J, Spies C, Takala J. Comfort and patient-centred care without excessive sedation: the eCASH concept. Intensive Care Med. 2016;42(6):962–71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Zagli, G., Viola, L. (2018). Critical Care Sedation: The Concept. In: De Gaudio, A., Romagnoli, S. (eds) Critical Care Sedation. Springer, Cham. https://doi.org/10.1007/978-3-319-59312-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-59312-8_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59311-1
Online ISBN: 978-3-319-59312-8
eBook Packages: MedicineMedicine (R0)